Pharmedic Pharmaceutical Medicinal JSC (HNX: PMC)

HNX: PMC Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Revenue	498,185	498,185	485,186	472,274	414,232	460,764
Revenue Growth (YoY)	2.68%	2.68%	2.73%	14.01%	-10.10%	-0.86%
Cost of Revenue	310,972	310,972	315,134	285,918	266,740	284,276
Gross Profit	187,213	187,213	170,053	186,356	147,492	176,488
Selling, General & Admin	96,729	96,729	85,645	95,588	74,912	90,801
Operating Expenses	96,729	96,729	85,645	95,588	74,912	90,801
Operating Income	90,484	90,484	84,408	90,768	72,580	85,687
Interest & Investment Income	-	-	19,853	13,178	9,363	7,803
Currency Exchange Gain (Loss)	-	-	1.08	-43.02	27.29	-104.1
Other Non Operating Income (Expenses)	9,829	9,829	165.06	-675.76	-1,022	55.09
EBT Excluding Unusual Items	100,313	100,313	104,427	103,227	80,949	93,441
Gain (Loss) on Sale of Assets	-	-	175.45	1,253	334.97	259.09
Pretax Income	100,313	100,313	104,602	104,480	81,284	93,700
Income Tax Expense	20,180	20,180	21,038	21,064	16,524	19,082
Net Income	80,133	80,133	83,564	83,416	64,760	74,618
Preferred Dividends & Other Adjustments	-	-	22,562	22,522	17,485	20,147
Net Income to Common	80,133	80,133	61,002	60,894	47,275	54,471
Net Income Growth	-4.11%	-4.11%	0.18%	28.81%	-13.21%	0.27%
Shares Outstanding (Basic)	13	13	9	9	9	9
Shares Outstanding (Diluted)	13	13	9	9	9	9
Shares Change (YoY)	36.99%	36.99%	-	-	-	-
EPS (Basic)	6268.00	6268.00	6536.47	6524.89	5065.55	5836.69
EPS (Diluted)	6268.00	6268.00	6536.00	6524.89	5065.55	5836.69
EPS Growth	-4.10%	-4.10%	0.17%	28.81%	-13.21%	0.27%
Free Cash Flow	39,227	39,227	86,678	31,675	58,885	71,003
Free Cash Flow Per Share	3068.32	3068.32	9287.65	3394.02	6309.62	7608.06
Dividend Per Share	-	-	19100.000	3000.000	2400.000	-
Dividend Growth	-	-	536.67%	25.00%	-	-
Gross Margin	37.58%	37.58%	35.05%	39.46%	35.61%	38.30%
Operating Margin	18.16%	18.16%	17.40%	19.22%	17.52%	18.60%
Profit Margin	16.09%	16.09%	12.57%	12.89%	11.41%	11.82%
Free Cash Flow Margin	7.87%	7.87%	17.86%	6.71%	14.22%	15.41%
EBITDA	101,916	101,916	96,124	103,311	86,549	100,040
EBITDA Margin	20.46%	20.46%	19.81%	21.88%	20.89%	21.71%
D&A For EBITDA	11,432	11,432	11,716	12,543	13,968	14,353
EBIT	90,484	90,484	84,408	90,768	72,580	85,687
EBIT Margin	18.16%	18.16%	17.40%	19.22%	17.52%	18.60%
Effective Tax Rate	20.12%	20.12%	20.11%	20.16%	20.33%	20.36%
Revenue as Reported	498,185	498,185	485,186	472,274	414,232	460,764

Source: S&P Capital IQ. Standard template. Financial Sources.